Imedex, LLC Would Like to Present Their 2012 Continuing Medical Education Events
Alpharetta, GA (PRWEB) December 01, 2011
Imedex, LLC would like to present the 2012 live Continuing Medical Education Events. Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals. Imedex® develops high quality, scientific programming that translates the latest research into clinically relevant information. The live continuing medical education activities have exceptional organization and outstanding educational value, with a proven sustained impact on disease management. The continuing medical education programs focus on improving patient care around the world. With over 50,000 e-learning experiences annually and more than 97,000 live meeting attendees since 2001, Imedex® truly educates the global healthcare community. At Imedex®, we believe that “education is the best medicine. ®”
The list of the 2012 Imedex, LLC events are as follows:
Event: 18th Annual Network of Oncology Clinicians and Researchers (NOCR) Meeting
When/Where: February 9-11, 2012 in Las Vegas, Nevada in Caesar’s Palace @ 3:30pm
Oncology CME Event Summary: This annual update features clinical case and panel discussions, debates, and Meet the Expert sessions for exchanging the latest information on the diagnosis and management of solid tumors and hematologic malignancies. For 2012, the agenda will expand to include discussions on sarcoma and GIST, cutting-edge research in melanoma, and a special session on managing women’s issues in oncology. The agenda will also continue with concurrent half-day workshops on oncology symptom management and lymphoma-myeloma.
Target Audience: Oncologists, hematologists, and other healthcare professionals (including oncology nurses and pharmacists) involved and/or interested in the care of patients with cancer.
Register for Oncology CME
Event: 8th European Congress On Hematologic Malignancies: From Clinical Science To Clinical Practice
When/Where: February 24-26, 2012 in Amsterdam: The Netherlands
Oncology CME Event Summary: In its eight year, the 2012 Congress encompasses hematologic malignancies, including myeloma, lymphoma, and leukemia, as well as discussions on screening, diagnosis and the latest management options. The focus of the 2012 Congress is to provide a forum to review state-of-the-art and present new data, as well as give attendees the opportunity to exchange ideas with world-renowned opinion leaders in the field.
Oncology CME Faculty: Elias Campo, MD, PhD (University of Barcelona), Bertrand Coiffier, MD (Hospices Civils de Lyon), Claire Dearden, MD (The Royal Marsden Hospital), Meletios A. Dimopoulos, MD (University of Athens School of Medicine), Martin Dreyling, MD (University Hospital Munich), Michael Hallek, MD (University of Cologne), Olivier Hermine, MD, PhD (Hópital Necker), Peter Johnson, MD (Cancer Research UK Centre University of Southampton), Eva Kimby, MD, PhD (Karolinska Institute, Karolinska University Hospital), Hanneke Kluin-Nelemans, MD, Maria-Victoria Mateos, MD, PhD (University Hospital of Salamanca), Philippe Moreau, MD (University Hospital Nantes), Antonio Palumbo, MD (University of Torino), Gilles Salles, MD , PhD (Hospices Civils de Lyon), Marinus H.J. van Oers, MD, PhD (Academic Medical Center), Pier Luigi Zinzani, MD (University of Bologna)
Target Audience: Hematologists, oncologists, and other healthcare professionals (physicians, physicians-in-training, oncology nurses, pharmacists, physicians’ assistants
, etc.) involved and/or interested in the therapeutic management of patients with hematologic malignancies, including multiple myeloma, chronic lymphocytic leukemia, and Hodgkin’s and non-Hodgkin lymphomas.
Register for Oncology CME
Event: 13th European Congress: Perspectives in Lung Cancer
When/Where: March 9-10, 2012 in Amsterdam: The Netherlands
Oncology CME Event Summary: Guided by an interactive format, Perspectives in Lung Cancer will not only provide a comprehensive overview of the most significant advances in lung cancer treatment, but will also leave attendees with valuable take-home information. Lectures, meet-the-expert sessions, and panel discussions, will aid attendees in confirming their current practices, increase their knowledge of lung cancer and optimize their patient care.
Target Audience: Medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, and other physicians, clinicians, physicians-in-training, and healthcare professionals (nurses, pharmacists, physician assistants, etc.) involved and/or interested in the therapeutic management of patients with lung cancer.
Register for Oncology CME
Event: Great Debates And Updates In Inflammatory Bowel Diseases
When/Where: March 16-17, 2012 in New York, New York
Gastroenterology/Oncology CME Event Summary: Great Debates and Updates in IBD will focus on controversial areas in the management of patients with IBD, as nationally-recognized thought leaders take opposing sides on topics of interest to doctors and their patients.
Target Audience: Gastroenterologists, hospitalists, internists, physician assistants, nurses, surgeons, and other clinicians with an interest in treating patients with IBD inclusive of children, teens, and young adults.
Register for Gastroenterology CME
Event: Great Debates And Updates in GI Malignancies
When/Where: March 30-31, 2012
Gastroenterology/Oncology CME Event Summary: The Great Debates and Updates in GI Malignancies event will include didactic presentations by recognized thought leaders in conjunction with lively and interactive debates over some of the most controversial topics in the field.
Target Audience: Gastrointestinal oncologists, medical oncologists, gastroenterologists, radiation oncologists, gastrointestinal surgeons, pathologists, and other physicians in active clinical practice involved and/or interested in the diagnosis, treatment, and management of patients with GI malignancies.
Register for Gastroenterology/Oncology CME
Event: Great Debates And Updates in Gynecologic Malignancies
When/Where: April 27-28, 2012 in New York, New York @ 10:00am
Oncology CME Event Summary: Great Debates and Updates in Gynecologic Malignancies will offer attendees expert insight into the management of patients with gynecological cancers. Using didactic presentations in conjunction with lively and instructive debates, this comprehensive conference will give practicing clinicians a thorough analysis of all currently available and emerging data.
Target Audience: Gynecologists, oncologists, and other physicians, clinicians, physicians-in-training, and healthcare professionals (including physician assistants and clinical nurse practitioners) involved in the diagnosis and management of gynecologic cancers including ovarian, uterine, and cervical cancers.
Register for Gynecology/Oncology CME
Event: Great Debates And Updates in Hematologic Malignancies
When/Where: April 27-28, 2012 in New York, New York @ 7:00am
Oncology CME Event Summary: Covering the broad continuum of hematologic malignancies, from lymphoma to leukemia to myeloma to myeloproliferative disorders, this one-of-a-kind hematology conference has a broad appeal to attendees and provides the most substantial curriculum. The unique format will include didactic presentations, in conjunction with lively and interactive debates, covering some of the most controversial topics in the field.
Target Audience: Academic and community hematologists, oncologists, oncology nurses and other healthcare professionals involved and/or interested in the treatment of patients with hematologic malignancies.
Register for Oncology CME
Event: 2012 European Focus On Myeloproliferative Neoplasms And Myelodysplastic Syndromes
When/Where: May 4-5, 2012 in Lisbon, Portugal
Oncology CME Event Summary: The 2012 European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes Oncology CME event will be the first comprehensive Congress of its kind in Europe. This meeting promises to be a first-class educational event that focuses on the latest advances in MPD, MDS and MPN. At this Congress, attendees will network with nationally-recognized leaders in the fields of molecular biology, pathology, immunology, and translational and clinical research, as this Congress promises to be a stimulating, interactive educational opportunity for attendees.
Target Audience: Hematologists, oncologists, and other health-care professionals (physicians, physicians-in-training, oncology nurses, pharmacists, physicians’ assistants, etc.) involved and/or interested in the therapeutic management of patients with myelodysplastic syndromes and myeloproliferative diseases.
Register for Oncology CME
Event: Great Debates And Updates In Thoracic Malignancies
When/Where: May 5, 2012 in San Francisco, California @ 8:00am
Oncology CME Event Summary: During the scientific CME sessions, speakers and the audience will be able to exchange information through a “hands-on” computerized speaker-audience interaction system. With this state-of-the-art equipment, participants answer multiple-choice questions, and within seconds, the answers are calculated and projected on a screen in tabular or graphic form for all to see. This system maximizes the ability for attendees from diverse disciplines to see differing opinions and compare consensus between the speakers and each other.
Target Audience: Medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, and other physicians, clinicians, physicians-in-training, and health-care professionals (nurses, pharmacists, physician assistants, etc.) involved and/or interested in the therapeutic management of patients with lung and other thoracic cancers.
Register for Oncology CME
Event: ESMO 14th World Congress on Gastrointestinal Cancer
When/Where: June 27-30, 2012 in Barcelona, Spain
Gastrointestinal/Oncology CME Event Summary: The ESMO 14th World Congress on Gastrointestinal Cancer is the premier global event in the field, encompassing malignancies affecting every component of the gastrointestinal tract and aspects related to the care of patients with gastrointestinal cancer, including screening, diagnosis and the latest management options for common and uncommon tumors. It has been endorsed by leading professional societies and organizations.
Gastroenterology/Oncology CME Faculty: Nadir Arber, MD, MSc, MHA (Tel Aviv Medical Center), Andrés Cervantes, MD, PhD (Hospital Clinico de Valencia), Fortunato Ciardiello, MD, PhD (Second University of Naples), Mario Dicato, MD (Luxembourg Medical Center), Bengt Glimelius, MD, PhD (University of Uppsala), Richard M. Goldberg, MD (University of North Carolina), Axel Grothey, MD (Mayo Clinic), Karin Haustermans, MD, PhD (University Hospital Gasthuisberg), Yoon-Koo Kang, MD, PhD (University of Ulsan College of Medicine), David J. Kerr, MD, FRCP (University of Oxford), Roberto Labianca, MD (Riuniti Hospital), John L. Marshall, MD (Georgetown University), Bernard Nordlinger, MD (Ambroise Paré Hospital), Arnaud D. Roth, MD (Geneva University Hospital), Philippe Rougier, MD, PhD (University of Versailles), Wolff Schmiegel, MD,PhD (Ruhr-Universität Bochum), Josep Tabernero, MD, PhD (Vall d’Hebron University Hospital), Eric Van Cutsem, MD, PhD (University Hospital Gasthuisberg), Cornelius J.H. van de Velde, MD, PhD (Leiden University Medical Center) and John R. Zalcberg, MD, PhD (Peter MacCallum Cancer Center)
Target Audience: Practicing clinicians, gastroenterologists, hepatologists, surgeons, medical oncologists, radiation oncologists, and clinical researchers who wish to review and update their knowledge and management of cancers of the gastrointestinal tract.
Register for the Gastroenterology/Oncology CME
For more information about these 2012 Imedex Continuing Medical Education Oncology events or to register:
Email us at registration(at)imedex(dot)com
Call us toll-free at 1(855) 276-6855
Call us for international events at 1 (512) 583-8385
Fax us 1 (512) 583-8379
or
Online at http://www.imedex.com
About Imedex, LLC
Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals. We develop high quality, scientific programming that translates the latest research into clinically relevant information. The activities have exceptional organization and outstanding educational value, with a proven sustained impact on disease management.
Our programs focus on improving patient care around the world. With over 50,000 e-learning experiences annually and more than 97,000 live meeting attendees since 2001, Imedex® truly educates the global healthcare community. At Imedex®, we believe that education is the best medicine.®
Release issued by Audience Generation, LLC
Audience Generation is a forward thinking agency at the forefront of the digital revolution and is a nationally and internationally recognized provider of integrated marketing, advertising, and technology services and solutions that offer a new way to find, generate, and engage live, online, social and mobile audiences where they exist on demand.
Audience Generation is known for its creative strategy, actionable solutions and measurable approach to transforming the ways brands interact with their target audience where they exist in person, online, via social networks or on their mobile devices.
Audience Generation has produced winning traditional, online, e-commerce, social and mobile campaigns including mobile application solutions for Fortune 500, small and medium businesses, not-for-profit organizations, national and international associations and societies, and venture backed start-up companies across a variety of industry verticals around the World.
To learn how Audience Generation can find your ideal customer, reach them where they exist, build your brand and grow your bottom line please call us at 512-708-4678 or email them at growyourbusiness(at)audiencegeneration(dot)com or visit them at: http://www.audiencegeneration.com.
###
©Copyright 1997-
, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.
©Copyright 1997-